Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000886163-17-000106
Filing Date
2017-08-22
Accepted
2017-08-22 12:50:23
Documents
1
Period of Report
2017-08-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_150342057116504.html 4  
1 FORM 4 wf-form4_150342057116504.xml 4 5394
  Complete submission text file 0000886163-17-000106.txt   6841
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LIGAND PHARMACEUTICALS INCORPORATED 3911 SORRENTO VALLEY BOULEVARD, STE 110 SAN DIEGO CA 92121
Business Address
Gray Nancy Ryan (Reporting) CIK: 0001714949 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33093 | Film No.: 171044649